Blockchain Registration Transaction Record

HeartBeam Appoints CEO Robert Eno to Board of Directors for Commercial Launch of 3D ECG Technology

HeartBeam (NASDAQ: BEAT) appoints CEO Robert Eno to Board of Directors for the launch of 3D ECG technology pending FDA clearance. Learn how their innovative approach could transform cardiac care outside medical facilities.

HeartBeam Appoints CEO Robert Eno to Board of Directors for Commercial Launch of 3D ECG Technology

This news matters as it highlights the advancements in personalized cardiac care by HeartBeam, showcasing innovative technology that could redefine how cardiac health is managed. The appointment of CEO Robert Eno signifies a strategic move towards commercializing their groundbreaking 3D ECG technology, potentially impacting the future of cardiac care for patients and physicians alike.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x5227b9ea93644d34b71bd9bc24880de2a3ae10ddd71491258482832754645610
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintbestCsBh-1da466ddb31a48247a757cc5f315e614